← Back to headlines
J&J's Darzalex Receives Approval for First Self-Administered Cancer Injectable
Johnson & Johnson's Darzalex has secured approval for its self-administered injectable formulation, marking a significant milestone as the first of its kind for cancer treatment.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
